ArticleTranslational animal science2025
Effect of beta-agonist type and timing of Experior feeding on calculated cumulative ammonia gas emissions, live growth performance, and carcass outcomes, and objective tenderness outcomes of feedlot steers.
Article in Translational animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The supplementation of lubabegron or ractopamine hydrochloride in the summer improved growth performance but did not impact rumination, mobility scores, and behaviors in feedlot cattle in the United States†.Journal of animal science · 2026Article
- The effect of lubabegron fumarate feeding duration on the growth performance and carcass characteristics of finishing steers.Translational animal science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our objective was to compare beta-agonist feeding strategies and evaluate Experior (EXP) with added days on feed (DOF) for live growth performance and carcass outcomes. Steers (n = 2,517; initial BW = 336 ± 23 kg) were allocated to 36 pens in a randomized, complete-block design and assigned to 1 of 6 treatments. Treatments were negative control (no beta-ligand; CON), Optaflexx (ractopamine hydrochloride, 300 mg·head
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.